Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular
Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Exonate Ltd., a biotechnology company developing novel
Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna's antisense
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ.
EXONATE APPOINTS DR RAFIQ HASAN AS NON-EXECUTIVE DIRECTOR Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens